Diacetylnalorphine

Diacetylnalorphine is a semi-synthetic opioid derivative of nalorphine. It is chemically related to heroin (diacetylmorphine) and is part of the opioid class of drugs. Diacetylnalorphine is synthesized by acetylating nalorphine, which itself is a derivative of morphine.
Chemical Properties[edit]
Diacetylnalorphine is characterized by the presence of two acetyl groups attached to the nalorphine molecule. This modification alters its pharmacokinetic and pharmacodynamic properties compared to its parent compound. The chemical structure of diacetylnalorphine is depicted in the adjacent image.
Pharmacology[edit]
Diacetylnalorphine acts on the opioid receptors in the central nervous system. It has both agonistic and antagonistic properties, similar to nalorphine, but the acetylation may affect its potency and duration of action. The drug's effects include analgesia, sedation, and euphoria, but it can also cause respiratory depression and other opioid-related side effects.
Medical Use[edit]
Diacetylnalorphine has been studied for its potential use in pain management and as a treatment for opioid addiction. However, its clinical use is limited due to the availability of other more effective and safer opioid medications. The risk of abuse and dependence also limits its therapeutic application.
Synthesis[edit]
The synthesis of diacetylnalorphine involves the acetylation of nalorphine using acetic anhydride. This chemical reaction introduces acetyl groups to the hydroxyl groups present in the nalorphine molecule, resulting in the formation of diacetylnalorphine.
Legal Status[edit]
Due to its potential for abuse and addiction, diacetylnalorphine is classified as a controlled substance in many countries. Its legal status is similar to that of other opioids, and it is subject to strict regulations regarding its manufacture, distribution, and use.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian